Budget 2023Budget 2023

Suven Pharma: Street worries on lack of clarity on post-merger strategy

The entry of Advent helps to bring in global reach and a platform to provide drug life cycle management services

December 27, 2022 / 10:39 AM IST
Suven Pharma: Street worries on lack of clarity on post-merger strategy

PRO Only Highlights
Quarterly performance largely backed by improved realisations
Medium-term triggers China plus and protectionist measures for tyre industry
Valuations not inexpensive; but improved medium-term outlook

Highlights Advent to buy 50.1 percent stake at current market price Advent plans to merge portfolio CDMO/API companies with Suven Deal to bring in life cycle management opportunity for Suven Combined margin profile to weaken Significant gestation period before substantial synergy is visible Promoters of Suven Pharmaceuticals (CMP: Rs 472; Market Cap: Rs 12,021 crore) have signed a definitive agreement to sell more than 50 percent stake to private equity player Advent International. This change in ownership puts to rest concerns about succession plans. Also, it...

  • PRO Panorama

    Moneycontrol Pro Panorama | Autos on the road to recovery

    Jan 25, 2023 / 03:44 PM IST

    In today’s edition of Moneycontrol Pro Panorama: Gland Pharma’s poor streak cause for concern, no signs of recovery for Colgat...

    Read Now
  • PRO Weekender

    Moneycontrol Pro Weekender: The downsizing of Davos Man

    Jan 21, 2023 / 10:10 AM IST

    The World Economic Forum has been desperately trying to reinvent itself, but Davos Man’s heydays are a thing of the past

    Read Now

To read the full story, Subscribe to Moneycontrol PRO

Access the exclusive stories, weekly investment ideas and daily technical calls in an Ad free experience

Already a member? Sign in

Limited Period offer on Moneycontrol PRO. Subscribe to PRO and get up to

50% OFF

What Do You Get

  • Ad free experience

    Experience a non-intrusive navigation and faster response in the ad free mode

  • Sharpest Opinions

    Access to 230+ exclusive stories per month from our editorial and Experts

  • +

    Have a Global edge with access to content from world renowned experts and journalist

  • Actionable Insights

    Access to 40+ weekly investment ideas including 4 daily technical calls

  • Virtual Events

    Exclusive access to live webinars from market experts on trading and investment strategies

  • Newsletters

    Daily and weekly insights bundled and sent to your inbox to keep you ahead in the race.

Get upto 50% discount on limited period offers